NCT06964399 The Effect of Reminiscence Therapy in Elderly
| NCT ID | NCT06964399 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Muş Alparslan University |
| Condition | Age-related Cognitive Decline |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2025-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-04-01 with a primary completion date of 2025-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study titled "Psychological Well-Being and Awareness in the Elderly: The Effect of Reminiscence Therapy", patients will be randomly divided into two groups as experimental and control groups. No intervention will be made to the patients in the control group. Reminiscence therapy will be applied to the patients in the experimental group. Participants will be asked to fill out the scale forms after accepting to participate in the study and obtaining their consent. In addition, after the reminiscence therapy is completed, the experimental and control groups will be asked to fill out the post-test forms. The following questions will be answered in the study; * Does reminiscence therapy affect the psychological well-being levels of the elderly? * Does reminiscence therapy affect the awareness levels of the elderly?
Eligibility Criteria
Inclusion Criteria: * Being over 65 years old * not having any serious psychiatric disorders * not having any diseases such as dementia etc. Exclusion Criteria: * Having a serious psychiatric disorder * Not being able to attend sessions during the research process
Contact & Investigator
Güzel Nur YILDIZ, Dr
PRINCIPAL INVESTIGATOR
Muş Alparslan University
Frequently Asked Questions
Who can join the NCT06964399 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 100 Years, studying Age-related Cognitive Decline. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06964399 currently recruiting?
Yes, NCT06964399 is actively recruiting participants. Contact the research team at sevdai_naram@hotmail.com for enrollment information.
Where is the NCT06964399 trial being conducted?
This trial is being conducted at Elâzığ, Turkey (Türkiye).
Who is sponsoring the NCT06964399 clinical trial?
NCT06964399 is sponsored by Muş Alparslan University. The principal investigator is Güzel Nur YILDIZ, Dr at Muş Alparslan University. The trial plans to enroll 90 participants.